(MADISON, N.J.)Wyeth said Wednesday its second-quarter profit fell 6.3 percent on charges for severance and other costs related to ongoing job cuts, but the drug developer still topped Wall Stree...READ MORE
(NEW YORK)Biotechnology company Amgen Inc. said Wednesday the Food and Drug Administration will not issue a much anticipated decision this week on whether to approve an experimental blood-cl...READ MORE
(WASHINGTON)Biotech drugmaker Amgen Inc. is expected to receive a decision this week from federal regulators on its experimental drug to treat a blood-clotting disorder.READ MORE
(NEW YORK)Shares throughout the biotechnology sector advanced Monday as Swiss pharmaceutical giant Roche offered to buy Genentech Inc. in potentially the biggest pharma-biotech deal of the y...READ MORE
Carl Icahn moved ahead with his attempt to overthrow Yahoo Inc.'s board of directors by submitting his final list of candidates Monday. The nominees remain the same as those he fir...READ MORE
(THOUSAND OAKS, Calif.)Biotechnology company Amgen Inc. said Business Wire erroneously released a statement from the company Monday, saying the Food and Drug Administration approved its Nplate treatment ...READ MORE
(THOUSAND OAKS, Calif.)Biotechnology company Amgen Inc. said Monday late-stage study results show its developing osteoporosis drug was more successful than placebo at building bone density in men undergo...READ MORE